Tenured rep here who totally agrees with everything you said. I do believe that Merck is purposefully stepping on tenured reps due to the state of the company/industry. They want the new, "cheap", reps, since they can no longer afford the expensive, tenured reps. Generics are taking over, pipeline isn't there to make up for the significant loss in revenue....they have to continue cutting costs. Would have been far better to have another round of overt layoffs than to have this covert tactic they have put in place...all in the guise of "career pathways". What a bunch of BS!